Phase 1 Study of LQT-1213 in Healthy Adults

Clinical Trial Summary

This is a single-center, randomized, double-blind, placebo-controlled study to be conducted in 2 parts: single ascending dose (SAD) incorporating a food effect arm and multiple ascending dose (MAD). Potential participants for each part will undergo screening procedures within 28 days of enrollment.

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04169100` - Novel Form of Acquired Long QT Syndrome	Phase 4
Completed	`NCT01648205` - Long-term Efficacy Study of Sodium Channel Blocker in LQT3 Patients	Phase 2
Recruiting	`NCT06087367` - Building of a Diagnostic/Prognostic Database for Human ERG Variant Effects
Recruiting	`NCT04675788` - Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening	Phase 4
Enrolling by invitation	`NCT05903313` - A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
Terminated	`NCT02439645` - A Registry to Determine the Clinical and Genetic Risk Factors for Torsade De Pointes
Recruiting	`NCT00221832` - Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases	N/A
Completed	`NCT04706104` - QT Measurement Techniques and Anesthesia Management
Recruiting	`NCT04336644` - Continuous Versus Intermittent cARdiac Electrical moNitorinG	N/A
Recruiting	`NCT02814981` - Hydroxyzine and Risk of Prolongation of QT Interval	N/A
Completed	`NCT02876380` - Prospective Identification of Long QT Syndrome in Fetal Life
Completed	`NCT02425189` - The Canadian National Long QT Syndrome Registry
Completed	`NCT00399412` - ECG Signal Collection From Long QT Syndrome, Wide QRS Complexes, Heart Failure, and Cardiac Resynchronization Patients	N/A
Completed	`NCT02513940` - Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes	Phase 4
Completed	`NCT02441829` - Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function	Phase 1
Completed	`NCT03182777` - Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies	N/A
Completed	`NCT01849003` - Study of the Effect of GS-6615 in Subjects With LQT-3	Phase 1
Completed	`NCT00316459` - Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy Subjects	Phase 1
Completed	`NCT00292032` - Registry of Unexplained Cardiac Arrest
Recruiting	`NCT05348564` - Comparing Direct vs Indirect Methods for Cascade Screening	N/A

NCT number	NCT05759962
Study type	Interventional
Source	Thryv Therapeutics, Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	September 14, 2022
Completion date	March 5, 2023

Phase 1 Study of LQT-1213 in Healthy Adults

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms